Australia markets open in 4 hours 29 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5399+0.0846 (+18.58%)
As of 03:19PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.21-0.14-0.230.03
Low estimate-0.21-0.14-0.230.03
High estimate-0.21-0.14-0.230.03
Year ago EPS-0.67-0.56-2.33-0.23
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate2.14M2.98M14.08M21.9M
Low estimate2.14M2.98M14.08M21.9M
High estimate2.14M2.98M14.08M21.9M
Year ago sales810k1.13M5.18M14.08M
Sales growth (year/est)164.20%163.50%171.80%55.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.58-0.73-0.62-0.5
Actual EPS-0.67-0.56-0.51-0.59
Difference-0.090.170.11-0.09
Surprise %-15.50%23.30%17.70%-18.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.14-0.230.03
7 days ago-0.21-0.14-0.230.03
30 days ago-0.21-0.14-0.23-0.08
60 days ago00-0.010
90 days ago00-0.010
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEVOKIndustrySector(s)S&P 500
Current qtr.68.70%N/AN/AN/A
Next qtr.75.00%N/AN/AN/A
Current year90.10%N/AN/AN/A
Next year113.00%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A